Welcome to Ascertain: Revolutionizing Healthcare Technology
Ascertain, a cutting-edge healthcare technology company based in NYC, has recently secured $10 million in Series A funding to further enhance its AI-powered solutions for care teams.
The funding round was spearheaded by Deerfield Management, with additional strategic support from Northwell Health, showcasing the industry’s confidence in Ascertain’s innovative approach.
Under the leadership of CEO Dr. Mark Michalski, Ascertain is dedicated to empowering health systems, payers, and independent provider groups with AI-driven case management solutions. By automating time-consuming administrative tasks like documentation, prior authorizations, and compliance, Ascertain enables care managers to prioritize patient care quality and efficiency.
Ascertain offers two primary solutions: Ascertain Automate, an enterprise software platform utilizing advanced AI to streamline administrative workflows, and tech-enabled services where Ascertain’s team manages entire workflows on behalf of the clients. These solutions cover a wide range of tasks, from prior authorization processes to patient scheduling, seamlessly integrating with existing systems for maximum efficiency.
One of Ascertain’s notable success stories includes a partnership with Northwell Health, where a pilot program was initiated to streamline authorization processes. By leveraging Ascertain’s AI technology, nurses, case managers, and other healthcare professionals were able to dedicate more time to patient care, resulting in improved overall efficiency.
Ascertain’s commitment to revolutionizing healthcare technology is evident in their results-driven approach and dedication to enhancing patient care experiences. With the recent influx of funding, Ascertain is poised to expand its reach and impact within the healthcare industry, driving innovation and efficiency across care teams.
Stay tuned for more updates from Ascertain as they continue to lead the way in AI-powered healthcare solutions.
